Total and Proteinase K-Resistant α-Synuclein Levels in Erythrocytes, Determined by their Ability to Bind Phospholipids, Associate with Parkinson's Disease

A marker for diagnosis of Parkinson's disease (PD), which reflects on the occurrence of peripheral pathogenic mechanisms, would potentially improve therapy. The significance of alpha-Synuclein (alpha-Syn) expression in red blood cells (RBC) is currently unclear. Here we investigated whether RBC's-expressed alpha-Syn may associate with PD. To this aim, we determined the levels of total and proteinase K-resistant alpha-Syn in samples of packed red blood cells (PRBCs). Twenty-one individuals with PD at various disease stages and 15 healthy controls, with similar demographic features, were recruited to this study. alpha-Syn levels were determined by their biochemical property to bind phospholipids, using a phospholipid-ELISA assay. A significantly lower ratio of total-to-proteinase K-resistant alpha-Syn levels was detected in PD patients than in the healthy control group. However, there was considerable overlap between the two groups. Suggesting a need for additional markers to be tested in combination with alpha-Syn levels. To the best of our knowledge, this is the first evidence for an association between RBCs-expressed alpha-Syn and pathogenic mechanisms involved in PD.